Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Thyroid Nodules

NCT03887611 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2019-03-26

No results posted yet for this study

Summary

The application of computer-aided diagnosis (CAD) technology "S-DetectTM" enables qualitative and quantitative automated analysis of ultrasound images to obtain objective, repeatable and more accurate diagnostic results. The Elastic Contrast Factor (ECI) technique, unlike conventional strain-elastic imaging techniques, can evaluate the elastic distribution in the region of interest. The purpose of the study was to evaluate the differential diagnosis value of ultrasound S-DetectTM technology for benign and malignant thyroid nodules and evaluate the consistency of ultrasound S-DetectTM technology and sonographer in the differential diagnosis of thyroid nodules and explore the differential diagnosis value of Samsung ultrasound ECI technology for benign and malignant thyroid nodules.

Conditions

  • Thyroid Nodule

Interventions

DEVICE

Ultrasound diagnosis

Ultrasound diagnosis of lesions with Samsung S-Detect and ECI technology

Sponsors & Collaborators

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER
  • Wuhan Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Macheng People's Hospital

    collaborator UNKNOWN
  • Huangshi Central Hospital

    collaborator OTHER
  • Affiliated Hospital of Jiangsu University

    collaborator OTHER
  • The First People's Hospital of Yichang

    collaborator UNKNOWN
  • Yichang Second People's Hospital

    collaborator OTHER
  • Xiangyang Central Hospital

    collaborator OTHER
  • The Second Hospital of Anhui Medical University

    collaborator OTHER
  • Anqing People's Hospital

    collaborator UNKNOWN
  • Huainan People's Hospital

    collaborator UNKNOWN
  • Taizhou Hospital

    collaborator OTHER
  • Wenzhou Central Hospital

    collaborator OTHER
  • Xuzhou First People's Hospital

    collaborator UNKNOWN
  • The Central Hospital of Lishui City

    collaborator OTHER
  • Huai'an First People's Hospital

    collaborator OTHER
  • WISCO General Hospital

    collaborator UNKNOWN
  • Jiangxia District First People's Hospital

    collaborator UNKNOWN
  • Enshi State Central Hospital

    collaborator UNKNOWN
  • Lianyungang Third People's Hospital

    collaborator UNKNOWN
  • First People's Hospital of Xianyang

    collaborator OTHER
  • Xin-Wu Cui

    lead OTHER

Principal Investigators

  • Xin-Wu Cui, PhD,MD · Tongji Hospital

  • You-Bin Deng, PhD,MD · Tongji Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-18
Primary Completion
2020-01-18
Completion
2020-03-18
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03887611 on ClinicalTrials.gov